Testing effectiveness (Phase 2)UnknownNCT00216268What this trial is testingTreatment of Japanese EncephalitisWho this might be right forJapanese Encephalitis Indian Council of Medical Research 200
Large-scale testing (Phase 3)Study completedNCT01150942What this trial is testingClinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in KoreaWho this might be right forJapanese Encephalitis Boryung Pharmaceutical Co., Ltd 205
Not applicableUnknownNCT06027801What this trial is testingIron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine ImmunogenicityWho this might be right forIron Deficiency Anemia University of Oxford 150
Large-scale testing (Phase 3)Study completedNCT00314132What this trial is testingSafety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.Who this might be right forEncephalitisJapanese Encephalitis Sanofi 2,004
Large-scale testing (Phase 3)Study completedNCT00735644What this trial is testingStudy of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the PhilippinesWho this might be right forJapanese EncephalitisHepatitis A Sanofi Pasteur, a Sanofi Company 1,200
Post-approval studies (Phase 4)UnknownNCT04817917What this trial is testingSeroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang ProvinceWho this might be right forJapanese EncephalitisVaccine Preventable DiseaseVaccine Reaction Zhejiang Provincial Center for Disease Control and Prevention 712
Post-approval studies (Phase 4)Study completedNCT02526550What this trial is testingImmunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAXWho this might be right forEncephalitis Siriraj Hospital 50
Post-approval studies (Phase 4)UnknownNCT03296410What this trial is testingThe Phase IVd of Inactivated Enterovirus 71 VaccineWho this might be right forHand, Foot and Mouth Disease (HFMD) Chinese Academy of Medical Sciences 1,220
Large-scale testing (Phase 3)UnknownNCT00938379What this trial is testingClinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRWho this might be right forMalariaDengueJapanese Encephalitis London School of Hygiene and Tropical Medicine 5,000
Testing effectiveness (Phase 2)Study completedNCT01943305What this trial is testingThe Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansWho this might be right forYellow FeverEncephalitis, Japanese Singapore General Hospital 84
Post-approval studies (Phase 4)Study completedNCT02880865What this trial is testingImmunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) VaccineWho this might be right forEncephalitis, JapaneseMeaslesMumps+1 more PATH 628
Large-scale testing (Phase 3)Study completedNCT00596271What this trial is testingConcomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440Who this might be right forJapanese Encephalitis Valneva Austria GmbH 192
Post-approval studies (Phase 4)Study completedNCT01567865What this trial is testingLot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 VaccineWho this might be right forJapanese Encephalitis PATH 818
Testing effectiveness (Phase 2)Study completedNCT00703521What this trial is testingRabies Immunization Concomitant With JEV in ChildrenWho this might be right forRabies Mahidol University 200
Post-approval studies (Phase 4)Study completedNCT01981967What this trial is testingPost-licensure Safety Study of IMOJEV® in ThailandWho this might be right forJapanese Encephalitis Sanofi Pasteur, a Sanofi Company 10,000
Post-approval studies (Phase 4)Study completedNCT01158599What this trial is testingThis is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly PopulationWho this might be right forJapanese Encephalitis Valneva Austria GmbH 200
Large-scale testing (Phase 3)Study completedNCT02492165What this trial is testingStudy of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy SubjectsWho this might be right forJapanese Encephalitis Sanofi Pasteur, a Sanofi Company 250
Large-scale testing (Phase 3)Study completedNCT00605085What this trial is testingSafety and Tolerability of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 2,675
Large-scale testing (Phase 3)Study completedNCT01092507What this trial is testingJapanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and ToddlersWho this might be right forEncephalitisJapanese Encephalitis Sanofi Pasteur, a Sanofi Company 300
Large-scale testing (Phase 3)Study completedNCT01466387What this trial is testingA Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsWho this might be right forMeningococcal DiseaseMeningococcal MeningitisTyphoid+3 more Novartis 552